ホームページへ
4.6/5
TrustPilot

トルコで最高のオクレリズマブ医師 - トップ4名の医師

トルコのトップオクレリズマブ医師と価格を比較。こちらで最適なマッチングを見つけてください

トルコ
すべての都市

トルコの3名のトップオクレリズマブ専門家から見積もりを取得

ご要望と予算に基づいて最適な医師を厳選いたします

医学的監修者 Fahad Mawlood

医学編集者・データサイエンティスト

トップ医師

4

トルコ

レビュー

14000+

実際の患者より

医師サービスで最良価格の国を選択

トップ各国のオクレリズマブ価格を比較

国をタップしてトップ医師と価格を表示

Ukraine
Turkey
Canada
France
Poland
Israel
$10,000 - $14,000
$10,000 - $15,000
$12,900 - $15,800
$15,000 - $25,000
$15,000 - $25,000
$16,500 - $22,800
$0
$4,000
$8,000
$12,000
$16,000
$20,000
$24,000

トルコのオクレリズマブでBookimed患者が実際に支払う費用

最も人気の範囲

$1.2K

$1.6K

$2K

$2.8K

$3.6K

$900 – $1,700

ほとんどの患者がこの範囲内でお支払いです

正確な費用は選択された医師、技術、治療部位、お客様の個別ニーズによって決まります

お客様のケースに正確な見積もりを取得

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

最初に表示：

Mustafa Solak

  • 5 優秀 • 1 レビュー
  • 20年の経験
  • 所在地： トルコ, イスタンブール
  • クリニック：
    4.6
    Hisar Hospital Intercontinental

  • Solak医師は、乳がん、肺がん、消化器がんなど様々な悪性腫瘍の治療を専門とし、Hacettepe大学がん研究所で高度な研修を修了している。

    • Hacettepe大学がん研究所にて腫瘍内科フェローシップを修了
    • テキサス大学MDアンダーソンがんセンターに勤務
    • 乳がん、精巣がん、卵巣がんの治療に豊富な経験を持つ
    • 頭頸部がんを専門とする
  • 続きを読む
診察
お問い合わせください

Baris Topcular

  • 新着
  • 20年の経験
  • 所在地： トルコ, イスタンブール
  • クリニック：
    5.0
    Istanbul Florence Nightingale Hospital

  • 一般情報および経歴

    彼はŞenlikköy小学校で初等教育を、Istek Foundation Florya Bilge Kagan中学校で中等教育を受けた。2001年にイスタンブール大学Cerrahpaşa医学部を卒業した。2006年にイスタンブール大学医学部神経内科学教室にて専門医教育を修了した。2006年にはスイス、バーゼル大学医学部PharmaZentrum神経内科クリニック・研究センターに勤務した。2007年から2011年まで、教授・博士Bakırköyのもと、Mazhar Osman精神・神経疾患研修研究病院の第3神経内科クリニックおよび認知症・運動障害外来に勤務した。2011年10月以降は、イスタンブール科学大学医学部神経内科に勤務している。

     

    経歴・勤務歴

    イスタンブール科学大学医学部神経内科、

    Şişli フローレンス・ナイチンゲール病院

    フローレンス・ナイチンゲール・カドゥキョイ病院神経内科、

    ガイレッテペ・メトロポリタン・フローレンス・ナイチンゲール病院PET部門。

     

  • 続きを読む
診察
お問い合わせください

Tahsin Ozatli

  • 新着
  • 2016年の経験
  • 所在地： トルコ, イスタンブール
  • クリニック：
    4.3
    Istinye University Liv Hospital Bahcesehir

  • この医師は、乳がん、肺がん、消化器系がんの治療を専門とする腫瘍学者です。現在、医師はIstinye Liv University Hospitalで診療を行っています。<\/p>

    多くの著名な機関でのキャリアを持ち、医師はMalatya State Hospitalで内科専門医として、Ankara Oncology Clinicで医師として、Erzurum Regional Training and Research Hospitalの腫瘍学部門のメンバーとして勤務してきました。<\/p>

    医師はSelcuk Universityの医学部を卒業し、2016年に准教授の称号を取得しました。<\/p>

  • 続きを読む
診察
お問い合わせください

Ela Simay Zengin

  • 新着
  • 5年の経験
  • 所在地： トルコ, イズミル
  • クリニック：Medicalpoint International Hospital

  • Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

    Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

    She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

  • 続きを読む
診察
お問い合わせください

海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。

ヤン・マツィイフスキー

医療コーディネーターチーム責任者

4300+件以上の患者の旅をガイド

Bookimedで3年

Turkeyの278名の患者が今月当社を通じて医師を見つけました

完璧な医師マッチングを取得する方法

1

2分のクイズ

目標、予算、スケジュールをお聞かせください

2

人間のマッチング + AI

アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します

3

オプション準備完了

価格、パッケージ、日程を比較。コーディネーターとチャット

選択肢に迷っていますか？

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

  • すべての段階で24時間365日サポート
  • 医師とのマッチングサポートとクリニックとの全てのコミュニケーションを処理
  • 旅行、宿泊、送迎を調整します

治療をガイド

医療訓練を受けた専属コーディネーター

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

適切な医師とクリニックの選び方：内部者のヒント

医師やクリニックを選ぶ際は、これらの重要なポイントを覚えておいてください：
資格を確認
ISAPS、JCI、または関連医学会などの機関からの認証を確認してください
成功率を確認
お客様の特定治療に豊富な経験と実績のある医師をお選びください
患者レビューを読む
実際の患者様のBookimedレビューをご覧になり、体験について学んでください
効果的なコミュニケーションの確保
円滑な治療のため言語サポートを提供するクリニックを選んでください。
サービスについて質問
隠れた費用を避けるため、価格に宿泊、現地送迎、アフターケアなどのサービスが含まれているかご確認ください

Bookimed洞察：トルコのトップオクレリズマブ専門家（2026）

Bookimedはトルコのオクレリズマブリクエスト8件を調整し、4名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています
順位医師経験適合する方特色クリニックと所在地診察
#1
Mustafa Solak
20年の経験乳癌および肺癌腫瘍学を専門とし、ハジェテペ大学がん研究所での研修およびMDアンダーソンがんセンターでの勤務経験を有する。
Hisar Hospital Intercontinental
トルコ
から $100

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the main benefits and potential risks of Ocrevus (ocrelizumab) therapy?

Ocrevus (ocrelizumab) effectively manages relapsing and primary progressive multiple sclerosis by depleting CD20-positive B cells. Key benefits include a 46% reduction in annual relapses and 25% slower disability progression. Potential risks involve infusion reactions, increased respiratory infection susceptibility, and rare cases of PML or liver injury.

  • Disease control: Reduces new brain lesions by 77–83% compared to standard interferon beta-1a treatments.
  • Mobility preservation: Delays wheelchair dependence by approximately 7 years in early primary progressive MS cases.
  • Infusion reactions: Affects 34–40% of patients, typically causing itching, rash, fever, or nausea.
  • Infection risk: Increases vulnerability to shingles, hepatitis B reactivation, and frequent respiratory infections.

Bookimed Expert Insight: While Ocrevus costs between $10,000 and $15,000 in Turkey, patients often overlook the significant savings compared to the $80,000 US average. Leading centers like Anadolu Medical Center or Medipol Mega utilize JCI-accredited protocols to manage the common 40% infusion reaction rate safely. Many patients successfully switch to this biannual dosing after failing daily medications, reporting near-zero relapses in the first 2 years.

Patient Consensus: Patients value the freedom of twice-yearly infusions over daily or weekly injections, often describing the results as life-changing for energy levels. Despite benefits, many emphasize the need for strict infection monitoring and suggest completing all necessary vaccinations before starting therapy.

Who is eligible for Ocrevus treatment in Turkey and what medical tests are required beforehand?

Eligibility for Ocrevus in Turkey requires a confirmed diagnosis of Relapsing Forms of Multiple Sclerosis or Primary Progressive Multiple Sclerosis based on McDonald criteria. Patients must be 18 or older, show recent disease activity via MRI, and test negative for active Hepatitis B infections.

  • Mandatory screenings: Patients must test negative for Hepatitis B, Hepatitis C, HIV, and Tuberculosis.
  • Neurological baseline: A brain MRI is required to document current central nervous system lesion load.
  • Immune evaluation: Doctors check quantitative serum immunoglobulins (IgG/IgM) and complete blood count baseline.
  • Vaccination protocol: Complete all non-live vaccinations 6 weeks before starting the first infusion cycle.

Bookimed Expert Insight: Data from top-tier Istanbul centers like Memorial Şişli Hospital shows a strict focus on JC virus serology. While not always mandatory globally, Turkish neurologists prioritize this test to mitigate PML risks. This higher diagnostic standard often explains why initial screening costs in Turkey range from お問い合わせください to お問い合わせください.

Patient Consensus: Patients emphasize that neurologists look for MRI lesions or relapses within the last 6 to 12 months. Most suggest planning for mild flu-like symptoms immediately following the first infusion session.

What is the typical administration schedule and monitoring protocol for Ocrevus infusions in Turkish hospitals?

Turkish hospitals follow international protocols for Ocrevus administration, starting with two 300 mg doses separated by 14 days. Maintenance involves a 600 mg infusion every 6 months. Centers like Anadolu Medical Center and Memorial Şişli Hospital require pre-medication and 60 minutes of post-infusion observation for safety.

  • Initial dosing: Two 300 mg infusions administered 14 days apart in week 0 and 2.
  • Maintenance schedule: Single 600 mg intravenous infusions delivered every 24 weeks following the first year.
  • Infusion time: Initial sessions last 3.5–4 hours, while maintenance infusions typically reduce to 2 hours.
  • Safety monitoring: Continuous tracking of heart rate, blood pressure, and oxygen levels every 15 minutes.
  • Pre-infusion screening: Required bloodwork includes Hepatitis B, liver enzymes, and quantitative serum immunoglobulin levels.

Bookimed Expert Insight: While most international protocols are identical, Turkish JCI-accredited centers often offer a faster discharge protocol. If your vital signs remain stable during the 1-hour post-infusion observation, neurological teams may clear you faster than in US clinics. This efficiency is common at high-volume centers like Medipol Mega University Hospital, which serves over 1,200 patients daily.

Patient Consensus: Patients recommend bringing snacks and entertainment for the initial long sessions. Most report feeling reassured by the mandatory pre-medication with steroids and antihistamines to prevent reactions.

Which internationally accredited clinics and neurologists in Turkey are experienced with Ocrevus therapy?

Internationally accredited Turkish hospitals like Memorial Sisli and Anadolu Medical Center offer specialized Ocrevus (ocrelizumab) therapy for multiple sclerosis. These facilities maintain Joint Commission International (JCI) standards and employ neurologists experienced in biologic protocols to ensure safe infusion administration and comprehensive monitoring.

  • Clinic accreditations: JCI-accredited centers like Memorial and Medipol follow international Johns Hopkins-affiliated protocols.
  • Expert neurologists: Specialists like Dr. Baris Topcular and Dr. Ela Simay Zengin manage biologic therapies.
  • Infusion safety: Hospitals provide dedicated infusion centers with 3 Tesla MRI and multidisciplinary support.
  • Geographic hub: Most experienced centers are in Istanbul, with specialized branches in Antalya and Izmir.

Bookimed Expert Insight: While many private clinics list MS services, specialized experience with ocrelizumab varies significantly. Medipol Mega University Hospital stands out because it operates as a massive academic complex with 70 departments, meaning neurology cases are reviewed by senior faculty who oversee high-volume biologic treatments. Choosing an academic-affiliated center often ensures access to the latest international clinical guidelines for complex MS cases.

Patient Consensus: Patients often find that private payment is required for Ocrevus in Turkey and recommend verifying infusion-center accreditation directly. It is common for international patients to request specific references regarding the number of biologic infusions a clinic performs annually.

What vaccination guidelines should patients follow before starting Ocrevus in Turkey?

Patients starting Ocrevus in Turkey must complete live-attenuated vaccines at least 4 to 6 weeks before their first infusion. Inactivated vaccines require a 2-week lead time. These windows ensure the immune system generates sufficient antibodies before B-cell depletion begins under specialist supervision.

  • Live vaccines: Complete MMR and varicella doses 4–6 weeks before starting treatment.
  • Hepatitis B screening: Mandatory HBsAg and anti-HBc testing is required before the first infusion.
  • Inactivated vaccines: Administer flu, pneumonia, and COVID-19 shots 2 weeks before therapy.
  • Infant safety: Delay live vaccines for newborns if Ocrevus was used during pregnancy.

Bookimed Expert Insight: Turkish neurology centers like Anadolu Medical Center or Medipol Mega often provide integrated screening for Hepatitis B and tuberculosis. Since Ocrevus in Turkey costs $10,000 to $15,000—well below the $80,000 US average—patients often use these savings to fund comprehensive pre-treatment titer testing for measles and varicella.

Patient Consensus: Patients emphasize checking varicella titers early as low immunity can delay the start date. Many suggest documenting all vaccinations upfront to meet local medical and reimbursement requirements smoothly.

How long do international patients usually stay in Turkey for Ocrevus initiation and follow-up infusions?

International patients typically stay in Turkey for 14 to 21 days during Ocrevus initiation to complete two loading doses spaced 14 days apart. Maintenance follow-up infusions, administered every 6 months, require a shorter stay of 4 to 5 days for clinical monitoring and observation.

  • Initiation stay: Plan for 14–21 days to cover both infusions and mandatory monitoring periods.
  • Maintenance stay: Budget 4–5 days for single infusions, including pre-medication and post-infusion observation.
  • Infusion duration: Expect 3–4 hours per session plus 1 hour of clinical observation afterward.
  • Clinic turnaround: Leading JCI-accredited hospitals typically begin treatment within 3–7 days of initial inquiry.

Bookimed Expert Insight: Anadolu Medical Center, an affiliate of Johns Hopkins Medicine, offers hotel booking services just 15 minutes away from the clinic. This proximity is vital for Ocrevus patients because protocols often require 24–48 hours of close monitoring after the first dose to manage potential reactions. Choosing a clinic with coordinated lodging can simplify the logistics of the two-week gap between initiation doses.

Patient Consensus: Patients emphasize staying at least 10 days for the initial trip to allow for overnight monitoring. Many successfully coordinate with home neurologists to handle bloodwork remotely, which streamlines follow-up visits to just a few days.

What should patients do if they experience adverse reactions after returning home from an Ocrevus infusion in Turkey?

Patients experiencing life-threatening reactions like difficulty breathing or severe swelling should immediately contact local emergency services. For non-urgent symptoms after returning home, patients must contact their Turkish treating clinic and their primary neurologist to manage infusion-related reactions and monitor for delayed complications like infections.

  • Emergency contact: Dial 112 immediately for throat swelling, chest tightness, or fainting symptoms.
  • Clinic notification: Contact specialists at Anadolu Medical Center or Medipol for non-emergency infusion reactions.
  • Symptom tracking: Document start times for redness, fatigue, or fever to share with doctors.
  • Neurological monitoring: Report new weakness or vision changes immediately to screen for rare infections.

Bookimed Expert Insight: Patients save up to 84% on Ocrevus in Turkey, with costs ranging from $10,000 to $15,000. High-volume centers like Anadolu Medical Center, affiliated with Johns Hopkins, offer personal coordinators who facilitate urgent remote consultations if reactions occur after you return home.

Patient Consensus: Many patients recommend having a pre-arranged telehealth appointment with your home neurologist within 48 hours of your return. Always carry a medical summary card listing Ocrevus as your current therapy when seeking any local medical care.